BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 15030337)

  • 41. A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 3. The relation between the tumour-associated lymphocyte infiltration and age and sex, tumour cell type, pigmentation, cellular atypia, mitotic count, depth of invasion, ulceration, tumour type and prognosis.
    Larsen TE; Grude TH
    Acta Pathol Microbiol Scand A; 1978 Nov; 86A(6):523-30. PubMed ID: 716913
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changing trends in melanoma treatment and the expanding role of the dermatologist.
    Brown MD; Johnson TM; Swanson NA
    Dermatol Clin; 1991 Oct; 9(4):657-67. PubMed ID: 1934641
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Survival following recurrent malignant melanoma of the head and neck.
    Hoyt DJ; Fisher SR
    Laryngoscope; 1989 Jun; 99(6 Pt 1):586-9. PubMed ID: 2725153
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cutaneous malignant melanoma in the older patient.
    Morris BT; Sober AJ
    Clin Geriatr Med; 1989 Feb; 5(1):171-81. PubMed ID: 2645995
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The influence of clinical and histopathological characteristics upon survival in melanoma patients.
    Lukács L
    Acta Chir Hung; 1990; 31(3):255-61. PubMed ID: 2097877
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prophylactic node dissection for malignant melanoma.
    Norvell ST; McCleave JJ; Bodurtha AJ; Irwin AC
    Can J Surg; 1977 Sep; 20(5):429-35. PubMed ID: 890616
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Melanoma of the head and neck in Auckland.
    Douglas RG; Shaw JH
    N Z Med J; 1987 Sep; 100(832):584-7. PubMed ID: 3452099
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Multiple primary cutaneous melanomas.
    Beardmore GL; Davis NC
    Arch Dermatol; 1975 May; 111(5):603-9. PubMed ID: 1130805
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cutaneous malignant melanoma in the older patient.
    Morris BT; Sober AJ
    Dermatol Clin; 1986 Jul; 4(3):473-80. PubMed ID: 3521992
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Malignant melanoma in the area of the head and neck].
    Christophers E; Rudert H
    HNO; 1986 Oct; 34(10):397-408. PubMed ID: 3793527
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A retrospective histological study of 669 cases of primary cutaneous malignant melanoma in clinical stage I. 4. The relation of cross-sectional profile, level of invasion, ulceration and vascular invasion to tumour type and prognosis.
    Larsen TE; Grude TH
    Acta Pathol Microbiol Scand A; 1979 Mar; 87A(2):131-8. PubMed ID: 433595
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of Excision Margin Size With Local Recurrence and Survival in Patients With T1a Melanoma at Critical Structures.
    Maurichi A; Barretta F; Patuzzo R; Sala L; Miceli R; Gallino G; Mattavelli I; Leva A; Simonotti N; Taglione B; Cossa M; Belotti A; Valeri B; Cortinovis U; Santinami M
    JAMA Dermatol; 2023 Jun; 159(6):587-595. PubMed ID: 37043209
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The influence of surgical margins and prognostic factors predicting the risk of local recurrence in 3445 patients with primary cutaneous melanoma.
    Urist MM; Balch CM; Soong S; Shaw HM; Milton GW; Maddox WA
    Cancer; 1985 Mar; 55(6):1398-402. PubMed ID: 3971310
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Malignant melanoma in childhood and adolescence.
    Melnik MK; Urdaneta LF; Al-Jurf AS; Foucar E; Jochimsen PR; Soper RT
    Am Surg; 1986 Mar; 52(3):142-7. PubMed ID: 3954260
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hazard-rate analysis in state I malignant melanoma.
    Rogers GS; Kopf AW; Rigel DS; Friedman RJ; Levenstein M; Bart RS
    Arch Dermatol; 1986 Sep; 122(9):999-1002. PubMed ID: 3740899
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical, histological and quantitative prognostic factors in cutaneous malignant melanoma.
    Karjalainen J; Eskelinen M; Kosma VM; Lipponen P; Tuominen L; Alhava E
    Anticancer Res; 1992; 12(5):1507-11. PubMed ID: 1444213
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adjuvant BCG immunotherapy for stage I and II malignant melanoma.
    Silver HK; Ibrahim EM; Evers JA; Thomas JW; Murray RN; Spinelli JJ
    Can Med Assoc J; 1983 Jun; 128(11):1291-5. PubMed ID: 6342739
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The possibility of performing an incisional biopsy in skin melanomas during pulsed laser radiation treatment].
    Vagner RI; Kozlov AP; Moskalik KG
    Vopr Onkol; 1990; 36(7):859-62. PubMed ID: 2399669
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Survival rates of patients with malignant melanoma of the skin.
    Pakkanen M
    Ann Chir Gynaecol; 1977; 66(1):31-5. PubMed ID: 848849
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Surgical treatment of dermatofibrosarcoma protuberans. A retrospective study of 20 cases with review of literature.
    Smola MG; Soyer HP; Scharnagl E
    Eur J Surg Oncol; 1991 Oct; 17(5):447-53. PubMed ID: 1936291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.